Logo Image
News|Articles|October 1, 2015

PTSM: Pharmaceutical Technology Sourcing and Management

  • PTSM: Pharmaceutical Technology Sourcing and Management-10-07-2015
  • Volume 11
  • Issue 10

Tecnandina’s Ecuador Facility Receives ANVISA Certification

The Grünenthal Group’s Tecnandina manufacturing plant in Ecuador has received the country’s first certification from the Regulatory Authority of Brazil.

The Grünenthal Group announced on Oct. 1, 2015 that its Tecnandina manufacturing plant in Ecuador has received certification from the Regulatory Authority of Brazil (ANVISA), making it the first production plant in Ecuador to receive ANVISA certification. The certification will allow the company to export pharmaceutical products to Brazil.

Tecnandina SA belongs to the Grünenthal Group, a research-based, pharmaceutical company headquartered in Aachen, Germany.taht offers contract manufacturing from five independent production plants throughout Europe and Latin America. The company manufactures and exports to 17 countries in Central and South America, Switzerland, and the Andean countries.

Source: Grünenthal Group

 

Articles in this issue

over 10 years ago

Cost Inhibits CMO Adoption of Single-Use Equipment

over 10 years ago

Low Temperature Needed for Complex Drug Candidates

over 10 years ago

FDA Plans Pilot Projects for Drug Supply Chain Security Act

over 10 years ago

Vetter Embarks on 300-Million Euro Manufacturing Expansion

over 10 years ago

Sterigenics International Adds Capacity

over 10 years ago

Hovione Expands Drug Substance Manufacturing

over 10 years ago

Piramal Introduces Proof of Concept Service for Next Wave of ADC Growth

almost 11 years ago

Patheon Unveils New Brand Identity

almost 11 years ago

FDA Releases Guidance on Generic-Drug Development

almost 11 years ago

Kopcha Selected to Head FDA’s Quality Office

Related Content